Invention Grant
- Patent Title: Use of edelfosine and other synthetic ether alkyl-lysophospholipids (APLs) for seizures and related diseases
-
Application No.: US14571511Application Date: 2014-12-16
-
Publication No.: US09717746B2Publication Date: 2017-08-01
- Inventor: Peter Andrew Ferchmin
- Applicant: Peter Andrew Ferchmin
- Agency: Harbin & Hein PLLC
- Main IPC: A61K31/075
- IPC: A61K31/075 ; A61K31/08 ; A61K31/14 ; A61K31/66 ; A61K31/661 ; A61K31/675
Abstract:
Synthetic ether alkyl-lysophospholipids (APLs) provide an effective treatment for subjects suffering from cholinergic seizures. Among other uses, APLs may be used to treat the effects of epileptic seizures in particular cholinergic seizures caused by exposure to insecticides or chemical warfare nerve agent exposure. Edelfosine, an APL, has been show to be particularly effective in these areas.
Public/Granted literature
Information query
